Washington Cancer Institute — Washington D.C., District of Columbia

Washington Cancer Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Washington Cancer Institute has participated in 38 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Breast Cancer.

Sponsors: Calithera Biosciences, Inc, Daiichi Sankyo, Exelixis.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington Cancer Institute?

Washington Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington Cancer Institute conducted?

Washington Cancer Institute has 38 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Breast Cancer.

Is Washington Cancer Institute accredited by Crixeo Health?

Washington Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.